The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Lysenko A.V.

Petrovsky Russian Research Center of Surgery

Salagaev G.I.

Petrovsky Russian Research Center of Surgery

Gilevskaya Yu.S.

Sechenov First Moscow State Medical University

Malmina A.I.

Sechenov First Moscow State Medical University

Belov Yu.V.

Petrovsky National Research Centre of Surgery

Redo surgical treatment of a patient with hypertrophic cardiomyopathy and recurrent left ventricular outflow tract obstruction

Authors:

Lysenko A.V., Salagaev G.I., Gilevskaya Yu.S., Malmina A.I., Belov Yu.V.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2025;(2): 123‑127

Read: 1602 times


To cite this article:

Lysenko AV, Salagaev GI, Gilevskaya YuS, Malmina AI, Belov YuV. Redo surgical treatment of a patient with hypertrophic cardiomyopathy and recurrent left ventricular outflow tract obstruction. Pirogov Russian Journal of Surgery. 2025;(2):123‑127. (In Russ.)
https://doi.org/10.17116/hirurgia2025021123

Recommended articles:
Meta-analysis on the rele­vance of septal myectomy in aortic valve replacement. Piro­gov Russian Journal of Surgery. 2025;(10-2):94-99
Redo frozen elephant trunk procedures after surgical treatment of acute aortic dissection type I. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(5):503-510
Redo asce­nding aortic surgery: outcomes and risk factors of complications. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(5):511-519
Sudden cardiac death in hype­rtrophic cardiomyopathy: can we really influence the risks. Russian Journal of Cardiology and Cardiovascular Surgery. 2026;(3):53-56

References:

  1. Arbelo E., Protonotarios A., Gimeno J. R. et al. ESC Scientific Document Group. 2023 ESC Guidelines for the management of cardiomyopathies: Developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC), European Heart Journal 2023; 44 (37): 3503-3626. https://doi.org/10.1093/eurheartj/ehad194
  2. Wan CK, Dearani JA, Sundt TM 3rd, Ommen SR, Schaff HV. What is the best surgical treatment for obstructive hypertrophic cardiomyopathy and degenerative mitral regurgitation? Ann Thorac Surg. 2009;88(3):727-731; discussion 731-732.  https://doi.org/10.1016/j.athoracsur.2009.05.052
  3. Cho YH, Quintana E, Schaff HV, Nishimura RA, Dearani JA, Abel MD, Ommen S. Residual and recurrent gradients after septal myectomy for hypertrophic cardiomyopathy-mechanisms of obstruction and outcomes of reoperation. J Thorac Cardiovasc Surg. 2014;148(3):909-915; discussion 915-916.  https://doi.org/10.1016/j.jtcvs.2014.05.028
  4. Minakata K, Dearani JA, Schaff HV, O’Leary PW, Ommen SR, Danielson GK. Mechanisms for recurrent left ventricular outflow tract obstruction after septal myectomy for obstructive hypertrophic cardiomyopathy. Ann Thorac Surg. 2005;80(3):851-856  https://doi.org/10.1016/j.athoracsur.2005.03.108
  5. Fatima B, Schaff HV, Stephens EH, King KS, Cetta F, Dearani JA. Incidence of Reoperation After Surgical Procedure for Left Ventricular Outflow Tract Obstruction in Children and Young Adults. Ann Thorac Surg. 2023;115(1):136-142  https://doi.org/10.1016/j.athoracsur.2022.08.018
  6. Griffeth EM, Dearani JA, Schaff HV, Johnson JN, Ackerman MJ, Bos JM, Alzate-Aguirre M, Todd A, Cannon BC, Wackel PL, Stephens EH. Septal Myectomy Outcomes in Children and Adolescents With Obstructive Hypertrophic Cardiomyopathy. Ann Thorac Surg. 2023;116(3):499-507.  https://doi.org/10.1016/j.athoracsur.2023.04.021
  7. Bockeria LA, Skopin II, Merzlyakov VYu, Klyuchnikov IV, Skopin AI, Lysenko AV. Transventricular surgical correction of mitral regurgitation in a patient with post-infarction left ventricular aneurysm. Thoracic and Cardiovascular Surgery. 2006;3:60-63. (In Russ.).
  8. Lysenko AV, Salagaev GI, Lednev PV, Belov YuV. Surgical treatment of a patient with hypertrophic obstructive cardiomyopathy and p.Arg456Gln mutation in the PRKAG2 gene. Kardiologiya i Serdechno-Sosudistaya Khirurgiya. 2022;15(1):81-84. (In Russ.). https://doi.org/10.17116/kardio20221501181
  9. Lysenko AV, Salagaev GI, Lednev PV, Belov YuV. Surgical treatment of obstructive hypertrophic cardiomyopathy combined with muscle bridging of the left anterior descending artery. Pirogov Russian Journal of Surgery. 2022;(1):81-83. (In Russ.). https://doi.org/10.17116/hirurgia202201181
  10. Cui H, Nguyen A, Schaff HV. The Brockenbrough-Braunwald-Morrow sign. J Thorac Cardiovasc Surg. 2018;156(4):1614-1615. https://doi.org/10.1016/j.jtcvs.2018.04.095

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.